Utility of transcranial ultrasound in predicting Alzheimer's disease risk
Language English Country United States Media print
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
25298200
DOI
10.3233/jad-141803
PII: G31750416Q7118NH
Knihovny.cz E-resources
- Keywords
- Alzheimer's disease, breath-holding test, cerebrovascular reserve capacity, minimal cognitive impairment, transcranial color coded duplex ultrasonography, transcranial doppler sonography,
- MeSH
- Alzheimer Disease diagnostic imaging physiopathology MeSH
- Cognition Disorders etiology MeSH
- Humans MeSH
- Cerebrovascular Circulation physiology MeSH
- Ultrasonography, Doppler, Transcranial * MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
Alzheimer's disease (AD) is a progressive, neurodegenerative disease characterized by an increasing incidence. One of the pathologic processes that underlie this disorder is impairment of brain microvasculature. Transcranial ultrasound is a non-invasive examination of cerebral blood flow that can be employed as a simple and useful screening tool for assessing the vascular status of brain circulation in preclinical and clinical stages of AD. The objective of this review is to explore the utility of using a transcranial ultrasound to diagnose AD. With transcranial ultrasound, the most frequently studied parameters are cerebral blood flow velocities and pulsatility indices, cerebrovascular reserve capacity, and cerebral microembolization. On the basis of current knowledge, we recommend using as a transcranial Doppler sonography screening method of choice the assessment of cerebrovascular reserve capacity with breath-holding test.
References provided by Crossref.org